Back to results
US 2023/0265123 A1Published application
Peptides and formulations for cancer treatment
AssigneePeptinovo Biopharma, LLC
InventorReynold Homan
Life of this patent
Estimating the term…
Abstract
Novel amphiphilic peptide, peptide amphiphile lipid micelles, processes for making peptide amphiphile lipid micelles comprising an amphiphilic peptide and phospholipid and optionally comprising a cargo molecule, and methods of use.
Claims37
A peptide comprising an amino acid sequence:
- X1-X2-X3-X4-X5-X6-X7-X8-X9-X10-X11-X12-X13-X14-X15-X16-X17-X18-X19-X20, wherein:
- X1 is D;
- X2 is V, Aib, Amy, or Aml;
- X3 and X10 are each F;
- X4 and X19 are each Q;
- X5, X16, and X18 are each K;
- X6, X9, and X13 are each L;
- X7 and X14 are each independently selected from the group consisting of Aib, Amy, Aml, Amp, Amt;
- X8 and X15 are each E;
- X11 and X12 are each independently selected from the group consisting of Q and N;
- X17 is W;
- and X20 is V, (SEQ ID NO:12) wherein the peptide is optionally acylated at the N-terminus, amidated at the C-terminus, or both acylated at the N-terminus and amidated at the C-terminus and the peptide is from 20 to 24 amino acids in length.
9 more elements
A peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:7, SEQ ID NO:9, or SEQ ID NO:10, wherein the peptide is optionally acylated at the N-terminus, amidated at the C-terminus, or both acylated at the N-terminus and amidated at the C-terminus and the peptide is from 20 to 24 amino acid in length.
Dependencies are inferred from the claim text.